InvestSMART

Anteris Technologies Ltd (ASX:AVR)

ALERT: Price-sensitive ASX Announcement for AVR
Current share price for AVR : $11.370 2.53 (28.62%)+
Announcement
Release
22 Jan 2026 2:55PM
Price at Release
$8.840
Full Release
download
Summary
Anteris Technologies Global Corp is conducting a public offering of 34,782,609 shares of its common stock at a price of $5.75 per share. The prospectus supplement details the company's aim to use the proceeds for general corporate purposes. Anteris, a structural heart company, focuses on innovative medical devices, with its lead product being the DurAVR® Transcatheter Heart Valve System. This system targets aortic stenosis, a serious heart condition. The offering is integral to furthering Anteris’ development and commercialization efforts, with delivery of the securities expected by January 22, 2026.
Key Points
  • Public offering of 34,782,609 shares at $5.75 per share.
  • Proceeds to be used for general corporate purposes.
  • Focused on developing the DurAVR® Transcatheter Heart Valve System.
  • Targets aortic stenosis, a serious heart disease.
  • Securities delivery expected January 22, 2026.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should refer to the full announcement here for further information.